"synopsis" may belong to another edition of this title.
Federico Cappuzzo, MD, has been the Director of the medical oncology department at the Istituto Toscano Tumori-Ospedale Civile-Livorno in Livorno, Italy since January 2010. In November 1992, he graduated, summa cum laude, in medicine and surgery at the Palermo University. In November 1996, he gained a degree, summa cum laude, in medical oncology at Milan University, followed by the European Society for Medical Oncology (ESMO) certification in medical oncology in 1997. From 1997 to 1999, he was recipient of an ESMO Fellowship on Gene Therapy of Lung Cancer at Institut Gustave Roussy in Villejuif (Paris). He then was an attending physician at the thoracic oncology unit at the Medical University of South Carolina in Charleston from April 2000 to September 2000. For six years, from November 2000 to 2006, he was an assistant professor at Ospedale Bellaria in Bologna. From November 2006 to January 2010, Dr Cappuzzo was an assistant professor in medical oncology at Istituto Clinico Humanitas IRCCS in Rozzano (Milan), and from January 2004 to November 2004 he was a visiting associate professor in medical oncology at University of Colorado in Denver.
Dr Cappuzzo is a member of the Italian Association in Medical Oncology (AIOM), ESMO, American Society Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASCL), and since 2006 has been a member of the editorial board of Lung Cancer. In 2006 and 2009, he received research grants from the Italian Association for Cancer Research (AIRC) on targeted therapies in lung cancer and is the author of more than 130 papers in peer-review journals, mainly in translational research in lung cancer.
"About this title" may belong to another edition of this title.
Shipping:
£ 2.09
Within U.S.A.
Book Description Condition: New. Seller Inventory # 20921753-n
Book Description Soft Cover. Condition: new. Seller Inventory # 9783319030586
Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020086382
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783319030586_lsuk
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9783319030586
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide. 80 pp. Englisch. Seller Inventory # 9783319030586
Book Description Paperback. Condition: Brand New. 1st edition. 67 pages. 7.75x5.00x0.25 inches. In Stock. Seller Inventory # x-3319030582
Book Description Condition: New. Seller Inventory # 20921753-n
Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide. Seller Inventory # 9783319030586
Book Description Condition: New. Guide to Targeted Therapies: EGFR mutations in NSCLC Num Pages: 67 pages, 16 colour illustrations, biography. BIC Classification: MJCL; MJL. Category: (P) Professional & Vocational. Dimension: 130 x 204 x 4. Weight in Grams: 102. . 2014. 2014th Edition. Paperback. . . . . Seller Inventory # V9783319030586